Our results suggest that a considerable proportion of younger women with ovulatory disorders associated with FSH values in the menopausal range will spontaneously resume ovulation and some will conceive.
Introduction
During the normal menstrual cycle follicle stimulating hormone (FSH) and luteinising hormone (LH) concentrations follow a definite pattern with an early follicular phase peak of FSH and mid-cycle peaks of both FSH and LH.' 2 Single estimations of FSH provide an accurate assessment of the production of this hormone,3 and disorders of ovarian function can be characterised from the measurable serum FSH and LH values. 4 During the follicular phase FSH concentrations rarely exceed 10 U/I and during the mid-cycle peaks of FSH and LH, FSH values do not exceed 20 U/I and do not overlap with values seen in postmenopausal women.
The average age of menopause in women of European origin is about 50 years.5 6 For several years preceding the menopause FSH concentrations early in the cycle gradually rise7 and after the complete cessation of menses the FSH and LH concentrations remain raised. Episodic hypergonadotrophism before cessation of the menses may be followed by ovulation when FSH and LH values return to normal. 8 About 10% of all patients presenting with secondary amenorrhoea have FSH concentrations consistent with ovarian failure. 9 10 Some of these women are still at an age when further child-bearing is desired-for example, under 35-but, since no effective fertility treatment is available in the presence of raised FSH concentrations, a prognosis of permanent sterility is usually given. During the past decade, however, several isolated reports of pregnancies following a diagnosis of premature ovarian failure have appeared and a syndrome of "gonadotrophin resistance" has been proposed to explain these cases."-'7
We decided to study a group of younger women with raised 
Results
Of the 67 hypergonadotrophic patients, 50 presented with secondary amenorrhoea (greater than six months' duration) and 17 with oligomenorrhoea (menstrual intervals from six weeks to six months). Twenty-four patients remained amenorrhoeic, but surprisingly 26 had further menstrual bleeding and at least four of these had endocrinological evidence of ovarian follicular development. Seventeen women subsequently ovulated and six of these conceived (two patients on two occasions). Table I summarises the patients' details and shows that there were no significant differences between the patients with persistent amenorrhoea and those in whom ovarian function returned with regard to age at menarche, previous parity, age at time of diagnosis of raised FSH concentration, or the incidence of symptoms of oestrogen deprivation. All patients had normal serum prolactin concentrations. Most of the patients studied were free of associated illness or disease and were asymptomatic apart from their menstrual disturbance, hot flushes, or coital dryness. Two patients with blood dyscrasias (chronic myelogenous leukaemia and Hodgkin's disease, respectively) had had regular cycles before amenorrhoea, which started during cytotoxic chemotherapy and persisted after the treatment stopped. One patient with Addison's disease also suffered from hypothyroidism and oophoritis and did not ovulate during the follow-up period. Chromosome analysis was performed in only eight subjects, and one who developed persistent amenorrhoea was found to be a 44 XX/XO mosaic. Other incidental illnesses included epilepsy, diabetes, optic nerve atrophy, congenital hyperbilirubinaemia, and hyperthyroidism.
Gynaecological symptoms other than those due to oestrogen deficiency were few. Two patients were hirsute, but the problem antedated the presenting menstrual disturbance in both and neither was severely affected. Ovarian biopsy was performed in 17 cases, 10 at laparotomy and 7 laparoscopically. Six of these 17 patients had streak gonads (three unilateral). Laparoscopy permitted diagnosis of the six patients with streak gonads but was also associated with the only definitely inaccurate ovarian biopsy result, a finding noted by others.15 21 The three patients who remained anovulatory despite positive biopsies presumably represent cases of the "resistant ovary syndrome."11 Open biopsy at laparotomy to obtain a representative sample of ovarian tissue is therefore justified in patients with premature hypergonadotrophism who are anxious to conceive, since the prognostic advantages outweigh the risks22 of peritubal adhesion formation. Chromosomal abnormality, antineoplastic drug therapy, and autoimmune disorders are recognised causes of premature ovarian failure and were present in a few of our patients. Antibody studies and karyotyping were not performed in all subjects, however.
Most ofour patients could be deemed to have "constitutionally early menopause" when no further ovulation followed or "gonadotrophin resistant ovary syndrome" in the responsive group. It has been proposed that the latter disorder is due to an autoimmune-induced defect of FSH-receptor protein23 since the primordial follicles remaining in the ovary are resistant to both endogenous and exogenous gonadotrophins. In the absence of a coexistent autoimmune condition, in particular Addison's disease,24 the evidence for an immunological basis for premature menopause is scanty25 and not all reported pregnancies after an increase in FSH values in the menopausal range can be attributed to this syndrome.17 26 Gradually increasing follicular resistance with episodic hypergonadotrophism alternating with ovulatory cycles is not uncommon during the normal menopausal transition8 9(also J B Brown in lecture at 21st Annual Meeting of Endocrine Society of Australia, 1978) and may be due to a progressive reduction with age of follicular inhibin, which is thought to have a specific negative feedback effect on FSH. 27 We have recently observed two patients with ovulatory cycles (one of whom conceived) with "menopausal" FSH values in the early cycle which then fell before the mid-cycle ovulatory surge. this has been done with a sample of Australian doctors.' In a study of the incidence and management of female breast disease in one practice in Birmingham five general practitioners were interviewed about their policies for managing patients with breast symptoms, but only a brief account of their views was reported.2 One of the aims of the present study, which constitutes one part of a broader research project evaluating health education in breast cancer, was to investigate general practitioners' views on managing female breast disease. A further aim was to determine the proportion of women with breast symptoms who were referred to hospital and the proportion dealt with by general practitioners alone.
Methods
All 112 NHS general practitioners and trainees practising in the City of Southampton were sent a letter explaining the purpose of the study and asking them to participate. This was followed within a few days by a telephone call to the surgery to arrange an interview. All interviews were conducted by SN between January and March 1980. The semi-structured questionnaire* contained items about breast disease including the clinical management, cancer survival rates and risk factors, breast self-examination and other screening methods, and health education.
At the end of the interview each doctor was asked to record, for four weeks, all women seen with breast symptoms. A booklet was provided for this purpose which, when completed, provided information about the age and presenting symptoms of each woman together with the action taken by the general practitioner.
*Copies of the questionnaire are available from SN.
